Position in TEVA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$39,174,192
+$4,579,093 QoQ
Shares Held
1,300,604
+17.3% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AVIVA PLC holds $184,196,374 across 6 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
968,672 | $114,506,717 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
1,300,604 | $39,174,192 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
34,451 | $20,428,753 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
71,310 | $9,394,379 | |
| 5 | ALKS |
Alkermes plc.
|
15,354 | $542,917 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
15,695 | $149,416 |
All Filings in TEVA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39,174,192 | 1,300,604 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $34,595,099 | 1,108,462 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $22,695,770 | 1,123,553 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||